These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 555675)

  • 1. The present prophylactic trends of rubella and measles.
    Zardi O; Soubotian B
    Biochem Exp Biol; 1979; 15(3):223-8. PubMed ID: 555675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune status against measles and rubella among 4 Chilean groups of different ages].
    Valenzuela MT; Vega J; Leal I; Vicente M; Young V; Vera L; Fasce R; Ramírez E
    Rev Med Chil; 1999 Mar; 127(3):359-65. PubMed ID: 10436723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
    Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility to measles, rubella and parotitis in young adults].
    Bayas JM; Vilella A; Vidal J; Nebot X; Carbó JM; Navarro G; Prat A; Asenjo MA; Salleras L
    Med Clin (Barc); 1996 Apr; 106(15):561-4. PubMed ID: 8656753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Age of measles vaccination in Lombardy from the results of a seroepidemiological survey in Milan].
    Profeta ML; Ferrante P
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):549-54. PubMed ID: 570046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of antibodies to measles and rubella in Sana'a, Yemen.
    Sallam TA; Al-Jaufy AY; Al-Shaibany KS; Ghauth AB; Best JM
    Vaccine; 2006 Sep; 24(37-39):6304-8. PubMed ID: 16815602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
    Suárez J; Castañeda MR; Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Rodríguez Ferri EF
    Med Clin (Barc); 1993 Oct; 101(13):484-7. PubMed ID: 8231381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serological assay of measles and rubella immunity in a sample of infantile population in palermo (author's transl)].
    Arista S; Ammatuna P; Leggio M; Chiarini A
    Ann Sclavo; 1980; 22(1):42-8. PubMed ID: 7247483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against rubella].
    Rossolini A; Barberi A
    Pediatr Med Chir; 1984; 6(1):31-4. PubMed ID: 6531239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Finding of hemagglutination-inhibiting antibodies against German measles virus in normal subjects of different age groups].
    Grasso A; Vierucci A; Messina G; Dianzani F
    Nuovi Ann Ig Microbiol; 1968; 19(5):354-60. PubMed ID: 5716650
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
    Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B; Ziyaeyan M; Alborzi A; Mardaneh J
    Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA
    Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.